Journal Watch · Nature Methods · 2026
Atom-level enzyme active site scaffolding using RFdiffusion2.
These results highlight the potential of atomic-level generative modeling to create de novo enzymes directly from reaction mechanisms.
TL;DR
These results highlight the potential of atomic-level generative modeling to create de novo enzymes directly from reaction mechanisms.
Key findings
- We further design enzymes for three distinct catalytic mechanisms and identify active candidates after experimentally testing fewer than 96 sequences in each case.
- These results highlight the potential of atomic-level generative modeling to create de novo enzymes directly from reaction mechanisms.
What they did
Here we show that a new deep generative model, RoseTTAFold diffusion 2 (RFdiffusion2), overcomes these constraints by designing enzymes directly from functional group geometries without specifying residue order or performing inverse rotamer generation. RFdiffusion2 successfully generates scaffolds for all 41 active sites in a diverse benchmark, compared to 16 using previous methods.
Full abstract (original)
Background: Designing new enzymes typically begins with idealized arrangements of catalytic functional groups around a reaction transition state, then attempts to generate protein structures that precisely position these groups. Current AI-based methods can create active enzymes but require predefined residue positions and rely on reverse-building residue backbones from side-chain placements, which limits design flexibility.
What they did: Here we show that a new deep generative model, RoseTTAFold diffusion 2 (RFdiffusion2), overcomes these constraints by designing enzymes directly from functional group geometries without specifying residue order or performing inverse rotamer generation. RFdiffusion2 successfully generates scaffolds for all 41 active sites in a diverse benchmark, compared to 16 using previous methods.
Results & conclusions: We further design enzymes for three distinct catalytic mechanisms and identify active candidates after experimentally testing fewer than 96 sequences in each case. These results highlight the potential of atomic-level generative modeling to create de novo enzymes directly from reaction mechanisms.
Abstract © the authors / Nature Methods (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1038/s41592-025-02975-x · PubMed 41339749.
Why it matters for pharma & biotech
- Relevant to Biology & Life Sciences teams tracking Nature Methods for new targets, mechanisms and biomarkers.
- As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Nature Methods study find?
These results highlight the potential of atomic-level generative modeling to create de novo enzymes directly from reaction mechanisms.
What type of study is this?
It is a research study, published in Nature Methods in 2026. Here we show that a new deep generative model, RoseTTAFold diffusion 2 (RFdiffusion2), overcomes these constraints by designing enzymes directly from functional group geometries without specifying residue order or performing inverse rotamer generation.
Where can I read the original paper?
The original is at the publisher via DOI 10.1038/s41592-025-02975-x. PubMed ID: 41339749. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/atom-level-enzyme-active-site-scaffolding-using-rfdiffusion2-02975x/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides